《广州医药》
点击关注官方服务号追踪稿件状态

【重要服务提醒】《广州医药》杂志服务号已上线稿件查询功能

各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。

操作方式

微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。

《广州医药》编辑部

广州医药杂志服务号
论著

四子散中药封包药熨在股骨骨折患者术后疼痛及肿胀中的临床疗效及安全性

Clinical efficacy and safety of Sizi powder pack hot compress in postoperative pain and swelling of patients with femoral fracture surgery

:221-224
 
        目的 探究四子散中药封包药熨在股骨骨折术后疼痛及肿胀中的临床疗效及安全性。方法 选取2024年6月—2025年5月婺源县人民医院骨科收治的60例股骨骨折术后患者, 随机分为观察组(30例,常规治疗+四子散中药封包药熨)与对照组(30例,常规治疗)。比较两组治疗前后疼痛评分(NRS-11)、肿胀程度评分、C反应蛋白(CRP)、白细胞介素-6(IL-6)水平及不良事件发生率。结果 治疗前两组患者疼痛、肿胀评分、CRP、IL-6水平比较差异无统计学意义(P>0.05); 治疗1周后,观察组疼痛评分为(2.11±0.48)分、肿胀程度为(0.35±0.43)度、CRP为(12.23±3.12)mg/L、IL-6为(16.03±4.01)ng/L,均低于对照组的(3.54±0.56)分、(1.04±0.58)度、(24.31±4.51)mg/L、(23.19±6.75)ng/L,差异有统计学意义(P<0.001)。观察组与对照组均无发生不良事件。结论 四子散中药封包药熨可缓解股骨骨折术后疼痛及肿胀,安全性良好。
       Objective To explore the clinical efficacy and safety of Sizi powder pack hot compress in the treatment of pain and swelling after femoral fracture surgery.Methods From June 2024 to May 2025, 60 patients after femoral fracture surgery were admitted to the Orthopedics Department of Wuyuan County People's Hospital and randomly divided into observation group(30 cases, conventional treatment+Sizi power pack hot compress)and control group(30 cases, conventional treatment). The pain score(NRS-11), swelling score, CRP,IL-6 levels and incidence of adverse events before and after treatment were compared between the two groups.Results There was no significant difference in pain and swelling scores between the two groups before treatment(P>0.05).After 1 week of treatment, the pain score(2.11±0.48), swelling score(0.35±0.43), CRP(12.23±3.12 mg/L), IL-6(16.03±4.01 ng/L)levels in the observation group were significantly lower than those in the control group(3.54±0.56, 1.04±0.58, 24.31±4.51 mg/L, 16.03+4.01 ng/L), and the difference was statistically significant(P<0.001).There were no adverse events in the observation group or the control group.Conclusions Sizi power pack hot compress can significantly alleviate the pain and swelling after femoral fracture surgery,and with good safety.
论著

中深度镇静下行婴幼儿泪道探通术的临床疗效观察

Clinical observation of therapeutic effect of lacrimal duct probing in infants and young children under moderate and deep sedation

:1549-1554
 
       目的   探讨口服水合氯醛与鼻内给予右美托咪定中深度镇静下行泪道探通术治疗婴幼儿先天性泪道阻塞的疗效、并发症及安全性。方法   随机选择2021年2月—2023年6月在广州医科大学附属妇女儿童医疗中心就诊的先天性泪道阻塞患儿,将其分为观察组和对照组,观察组行中深度镇静后进行泪道探通术,对照组进行表麻下泪道探通术,对比两组的治愈率及并发症发生率。结果   观察组共76例(97眼),总治愈率98.97%,分为3组,6~12月龄组41例(53眼),12~18月龄组14例(15眼),18~36月龄组21例(29眼),对照组共84例(116眼),总治愈率93.10%,6~12月龄组55例(70眼),12~18月龄组15例(24眼),18~36月龄14例(22眼),观察组泪道探通术治愈率高于对照组,差异有统计学意义(χ 2 =4.49,P<0.05)。观察组一次探通的成功率为92.78%,高于对照组61.21%,差异有统计学意义(χ 2 =26.86,P<0.05)。观察组二次探通的成功率为85.71%,高于对照组44.44%,差异有统计学意义(χ 2 =4.13,P<0.05)。发生的并发症主要是出血、皮下水肿、感染、假道形成,观察组并发症的发生率4.12%,低于对照组15.52%,差异有统计学意义χ 2 =7.40,P<0.05)。观察组中2例患儿口服水合氯醛出现恶心呕吐,改为右美托咪定滴鼻。3例患儿右美托咪定滴鼻后出现口唇苍白,持续10~15 min即可缓解。其余均未有不良反应。结论   中深度镇静下给予婴幼儿泪道阻塞患儿行泪道探通术相比传统表麻下泪道探通术疗效更好,并发症较少,对孩子的心理创伤小,安全且经济实惠。
       Objective  To explore the efficacy,complications and safety of moderate and deep  sedation  under oral administration of chloral hydrate and intranasal administration of dexmedetomidine for the treatment of congenital nasolacrimal duct obstruction(CNLDO) in infants and young children.Methods  Children with CNLDO who visited our hospital from February 2021 to June 2023 were randomly selected and divided into the observation group and the control group.The observation group was performed with lacrimal duct probing after moderate and deep sedation,while the control group was performed with lacrimal duct probing under surface anesthesia.The cure rate and incidence of complications were compared between the two groups.Adverse reactions after using sedatives were observed.Results  The observation group consisted of 76 cases(97 eyes),with a total cure rate of 98.97%.They were divided into three groups:41 cases(53 eyes)in the aged 6-12 months group,14 cases(15 eyes)in the aged 12-18 months group,and 21 cases(29 eyes)in the aged 18-36 months group.The control group consisted of 84 cases(116 eyes),with a total cure rate of 93.10%.There were 55 cases(70 eyes)in the aged 6-12 months group,15 cases(24 eyes)in the aged 12-18 months group,and 14 cases(22 eyes)in the aged 18-36 months group.The cure rate of lacrimal duct probing in the observation group was significantly higher than that in the control group(χ 2 =4.49,P<0.05).The success  rate of the first probing in the observation group was 92.78%,significantly higher than that in the control group of 61.21%(χ 2 =26.86,P<0.05).The success rate of the second probing in the observation group was 85.71%,significantly higher than that in the control group of 44.44%(χ 2 =4.13,P<0.05).The incidence of complications mainly were bleeding,subcutaneous edema,infection,and false passage formation.The incidence of complications in the observation group was 4.12%,lower than that in the control group 15.52%,and the difference was statistically significant(χ 2 =7.40,P<0.05).Two cases in the observation group experienced nausea and vomiting after taking chloral hydrate orally,and were replaced with dexmedetomidine nasal drops.Three cases of pediatric patients showed pale lips after nasal administration of dexmedetomidine,which lasted for 10-15 minutes and could be relieved.No other adverse reactions were observed.Conclusions  Under moderate and deep sedation,lacrimal duct probing treatment for infants and young children with CNLDO showed better therapeutic effects,fewer complications,less psychological trauma to these patients,which is safe and cost-effective,and is suitable for promotion compared to under traditional surface anesthesia.
论著

PNF技术与居家康复联合治疗缺血性脑卒中患者的临床疗效

Clinical efficacy of PNF combined with home-based rehabilitation in patients with ischemic stroke

:1404-1408
 
目的 探究本体感觉神经肌肉促进疗法(PNF)技术与居家远程康复治疗对缺血性脑卒中患者凝血功能、平衡状态的影响。方法 选择2023年1月—2024年1月在宁乡市中医医院择期治疗的60例缺血性脑卒中患者为研究对象。按照患者选择的治疗方案进行分组, 观察组接受PNF技术联合居家远程康复指导治疗, 对照组接受常规居家远程康复指导治疗。记录疗效、凝血功能、神经功能缺损症状。结果 凝血功能方面,观察组治疗后活化部分凝血酶时间(APTT)、凝血酶原时间(PT)高于治疗前, 二聚体(D-D)、纤维蛋白原(FIB)低于治疗前,组间比较差异有统计学意义(P<0.05)。与对照组相比, 观察组的APTT、PT、D-D、FIB指标相近,组间比较差异无统计意义(P>0.05)。治疗后, 观察组平衡功能(BBS)评分比治疗前高, 组间比较差异有统计学意义(P<0.05)。观察组BBS评分、FMA评分、肌力等级更高, 组间比较差异有统计学意义(P<0.05)。结论 PNF技术+居家远程康复指导治疗可作为缺血性脑卒中患者治疗的有效手段。联合治疗后凝血功能、平衡状态、肢体功能状况、肌力明显改善, 可见联合治疗对于减轻患者病情尤为明显。
Objective To explore the effects of proprioceptive neuromuscular facilitation(PNF)and home-based remote rehabilitation on coagulation function and balance function in patients with ischemic stroke.Methods From January 2023 to January 2024, 60 patients with ischemic stroke were selected from our hospital.The patients were divided into two groups according to the treatment plan chosen by themselves.The patients in the observation group received PNF technology combined with home-based remote rehabilitation guidance, while the patients in the control group received routine home-based remote rehabilitation guidance.The curative effect, coagulation function and neurological deficit were recorded.Results After treatment, activated partial thrombin time(APTT)and prothrombin time(PT)were significantly higher, D-dimer(D-D)and fibrinogen(FIB)were significantly lower in the observation group than those before treatment(P<0.05).Compared with the control group, the APTT, PT, D-D and FIB of the observation group were similar, and there was no significant difference between the two groups(P>0.05).After treatment, the Berg Balance Scale score of the observation group was higher than that before treatment, and there was significant difference between the two groups(P<0.05).The Berg Balance Scale score, Fugl-Meyer Assessment score and muscle strength grade of observation group were higher than those of control group(P<0.05).Conclusions PNF combined with home-based remote rehabilitation can be used as an effective method for the treatment of patients with ischemic stroke.The coagulation function, balance, extremity function and muscle strength were significantly improved after combined treatment, which indicated that the combined treatment was especially effective in relieving the patients’ symptoms.
论著

内托生肌法治疗肉芽肿性乳腺炎溃后期的临床疗效

Clinical efficacy of endotropic muscle-generating therapy in treating late-stage ulcerative granulomatous mastitis

:888-894
 
目的 研究内托生肌法治疗肉芽肿性乳腺炎溃后期的临床疗效。方法 63例符合肉芽肿性乳腺炎溃后期的患者,分为西药组31例和中药组32例。西医药组予常规激素、抗生素等治疗,中药组予内托生肌法,加减组方,两组治疗时间为6个月。比较两组患者的疾病转归、乳房外形评价、临床症状观察评分等指标。结果 中药组6个月治愈率高于西药组,中药组临床治愈18例(56.2%)、痊愈11例(34.4%),相较于西药组临床治愈11例(35.5%)和痊愈9例(29%);治疗后中药组乳房外形评价优于西药组,中药组临床症状评分较低,组间比较差异具有统计学意义。两组患者治疗前后免疫球蛋白IgA、IgG、IgM水平比较差异均未见统计学意义。中药组相较于西药组不良反应更少,患者依从性更高。结论 内托生肌法治疗肉芽肿性乳腺炎溃后期能促进肉芽肿创面愈合,加快肉芽组织新生,改善破溃流脓症状以及在恢复乳房外观方面具有明显的优势。
Objective To study the clinical efficacy of endotropic muscle-generating therapy in treating late-stage ulcerative granulomatous mastitis.Methods Sixty-three eligible patients were included in the western medicine group(31 cases)and the traditional Chinese medicine group(32 cases).The western medicine group received conventional hormones and antibiotics,while the traditional Chinese medicine group received the endotropic muscle-generating method with adjustments.The treatment duration for both groups was six months.Disease regression,breast shape evaluation,clinical symptom observation scores,and other relevant indices of both groups were compared.Results The study found that the six-month cure rate in the traditional Chinese medicine group(56.2% clinically cured,34.4% cured)exceeded that of the western medicine group(35.5% clinically cured,29% cured).Breast appearance evaluation in the traditional Chinese medicine group significantly better that of the western medicine group post-treatment,and clinical symptom scores were lower,demonstrating a statistically significant difference.Before and after treatment,there was no significant difference in the levels of immunoglobulins A,G,and M observed between the two groups.The traditional Chinese medicine group exhibited fewer side effects and higher patient compliance compared to the western medicine group.Conclusions The endotropic muscle-generating method,when employed to treat granulomatous mastitis in the late ulcerative stage,proves effective in promoting granulomatous wound healing,accelerating the generation of new granulation tissue,and improving ulceration and pus flow symptoms.Additionally,it contributes to the restoration of breast appearance.
中西医结合/中医研究

靳三针联合解语丹治疗卒中后失语症的临床疗效研究

Clinical efficacy of Jin's Three Needle combined with Jieyu Dan in the treatment of aphasia after stroke

:416-422
 
目的 探索以解语丹联合靳三针为基础的不同治疗方案对卒中后失语症(PSA)的治疗效果。方法 收集广州市第一人民医院神经内科、中医科PSA患者120例,随机分为解语丹组、靳三针组、联合组和对照组,每组各30例。试验组除给予常规卒中治疗外,分别给予解语丹、靳三针及解语丹联合靳三针治疗,对照组仅给予常规卒中治疗,治疗周期共12周。分别利用西方失语成套测验(WAB)、汉语失语检查量表(ABC)、副反应量表(TESS)于试验前、试验2周及12周时对患者进行评估,并进行药物安全性评价,观察解语丹联合靳三针治疗卒中后失语症的临床治疗效果。结果 经2周治疗后,试验组各组WAB中的失语指数(AQ)、操作指数(PQ)、大脑皮质指数(CQ)评分分别为68.14±7.23;67.26±7.23;69.73±6.97、15.47±3.91;15.92±6.35;18.06±7.83、66.84±7.85;65.78±6.75;70.35±6.73,均较治疗前及对照组有明显改善,比较差异有统计学意义(P<0.05);试验组各组比较,联合组各项评分优于解语丹组和靳三针组,比较差异有统计学意义(P<0.05);治疗12周后,试验组WAB的AQ、PQ、CQ评分分别为91.87±7.81;85.75±6.87;94.58±7.83、31.57±7.38;25.67±6.28;35.72±8.31、89.74±6.98;84.16±6.79;93.56±7.88,与治疗2周后比较,差异有统计学意义(P<0.05)。言语功能各亚项评分显示,联合组在口语表达、听理解、复述、命名等方面优于其他各组,两两比较差异有统计学(P<0.05)。试验各组在2周及12周时,TESS评分比较差异无统计学意义(P<0.05)。统计分析表明,解语丹联合靳三针治疗卒中后失语症,2周后起效12周后效果更为明显。结论 解语丹联合靳三针早期治疗PSA患者能有效提升认知功能,改善患者的言语功能,提高患者的人际交往和生活自理能力,且具有较好的安全性,无严重不良反应,可为临床治疗PSA提供一种新的方法。
Objective To compare the therapeutic effects of different treatment plans based on Jieyu Dan combined with Jin's Three Needle on aphasia patients after stroke.Methods A total of 120 patients with aphasia after stroke in the neurology and traditional Chinese medicine departments of Guangzhou First People's Hospital were collected and randomly divided into Jieyu Dan group,Jin's Three Needle group,combined group and control group,with 30 cases in each group.The treatment groups were treated with Jieyu Dan,Jin's Three Needle and Jieyu Dan combined with Jin's Three Needle respectively,in addition to conventional stroke treatment.The control group was only treated with conventional stroke treatment,with a total treatment period of 12 weeks.The Western Aphasia Battery(WAB),Aphasia Battery of Chinese(ABC)and Treatment Emergent Symptom Scale(TESS)were used to evaluate patients before,at 2 weeks and 12 weeks of the trial,and drug safety was evaluated to observe the clinical therapeutic effect of Jieyu Dan combined with Jin's Three Needle in treating post stroke aphasia.Results After 2 weeks of treatment,the aphasia quotient(AQ),performance quotient(PQ),cortical quotient(CQ)scores of WAB in each group of the experimental group were 68.14±7.23,67.26±7.23,69.73±6.97;15.47±3.91,15.92±6.35,18.06±7.83;66.84±7.85,65.78±6.75,70.35±6.73,respectively,and all significantly improved compared to before treatment and the control group,with significant differences(P<0.05).Compared with the experimental group,the combined group had better scores than the Jieyu Dan group and Jin's Three Needle group,with a statistically significant difference(P<0.05).After 12 weeks of treatment,the AQ,PQ,and CQ scores of the experimental group's WAB were 91.87±7.81,85.75±6.87,94.58±7.83;31.57±7.38,25.67±6.28,35.72±8.31;89.74±6.98,84.16±6.79,93.56±7.88,respectively.Compared with 2 weeks of treatment,the difference was statistically significant(P<0.05).The scores of each sub item of speech function showed that the combined group was significantly better than the other groups in terms of oral expression,listening comprehension,retelling,naming,etc.,with statistical significance(P<0.05).At 2 and 12 weeks,there were no significant statistical differences in TESS scores among the experimental groups(P<0.05).Statistical analysis showed that the combination of Jieyu Dan and Jin's Three Needle in the treatment of post-stroke aphasia had a more significant effect after 2 weeks and 12 weeks.Conclusions The combination of Jieyu Dan and Jin's Three Needle can effectively improve cognitive function and enhance patients' self-care ability in the early treatment of aphasia after stroke.The clinical efficacy is significant and has good safety,making it an effective treatment plan for aphasia after stroke.
论著

茵栀黄口服液、还原型谷胱甘肽联合光疗对新生儿黄疸的临床疗效

:392-396
 
目的 探讨茵栀黄口服液、还原型谷胱甘肽联合光疗对新生儿黄疸的临床疗效。方法 以2020年2月—2023年3月河南省驻马店市中医院收治的100例黄疸患儿为研究对象。按照随机数字表法分为A组和B组,每组各50例。A组和B组患儿均接受蓝光治疗,B组予以还原型谷胱甘肽治疗,A组在B组的基础上联合茵栀黄口服液。观察A组和B组患儿临床疗效、黄疸消退时间、胆红素水平、T淋巴细胞亚群以及不良反应发生情况。结果 A组总有效率高于B组(96.00% vs 82.00%)(P<0.05);治疗7 d后,A组和B组患儿组总胆红素、间接胆红素、直接胆红素水平均低于治疗前,且A组低于B组(P<0.05);A组和B组患儿组CD3+、CD4+、CD4+/CD8+均高于治疗前且A组高于B组,A组和B组CD8+低于治疗前且A组低于B组(P<0.05);A组皮疹、腹泻等不良反应的总发生率和B组组间对比差异无统计学意义(10.00% vs 6.00%,P>0.05)。结论 茵栀黄口服液联合还原型谷胱甘肽和光疗用于新生儿黄疸的治疗中可加快总胆红素水平的降低,改善T淋巴细胞亚群,进而提高临床疗效且不增加不良反应。
论著

血浆置换治疗抗MDA5阳性皮肌炎伴肺间质纤维化临床疗效及安全性分析

Clinical efficacy and safety analysis of plasmapheresis for anti-MDA 5 positive dermatomositis with lung interstitial fibrosis

:1166-1171
 
目的 探讨血浆置换联合泼尼松(PDN)联合环磷酰胺(CTX)治疗抗黑色素瘤分化相关基因5(MDA5)抗体阳性皮肌炎(DM)伴肺间质纤维化(ILD)患者疗效及安全性。方法 回顾性分析2014年6月—2023年6月普洱市人民医院诊断的MDA5阳性DM伴ILD患者40例,其中治疗组20例,采用血浆置换联合PDN 1 mg/kg每日1次口服,4周后减量,每周减总量10%,CTX 1 g每月1次静脉滴注,共6次治疗;另20例设为对照组,采用PDN 1 mg/kg每日1次口服,4周后减量,每周减总量10%,CTX 1 g每月1次静脉滴注,共6次治疗,分别于治疗后3月、6月检测一氧化碳弥散量(DLCO)、第1秒用力呼气量(FEV1),血清铁蛋白(SF)、C-反应蛋白(CRP)、涎液化糖链抗原(KL-6)、MDA5转阴率行疗效评估。结果 在治疗3个月和6个月时,两组患者的DLCO、FEV1、SF、CRP、KL-6、MDA5转阴率等指标的完全缓解率不一致。其中,3个月时,治疗组上述指标的完全缓解率依次为95%、85%、90%、90%、90%、85%,对照组依次为15%、20%、20%、15%、0%、0%。两组患者在治疗3个月的DLCO、FEV1、SF、CRP、KL-6水平和MDA5转阴数均有所不同。其中治疗组的DLCO、KL-6、CRP水平均较对照组降低(P<0.01),治疗组FEV1水平较对照组升高(P<0.01),治疗组SF水平较对照组降低(P<0.05),两组治疗6个月时,治疗组上述指标缓解率依次为95%、85%、90%、90%、90%、85%,对照组依次为20%、25%、20%、20%、20%、5%。两组患者在DLCO、FEV1、SF、CRP、KL-6水平以及MDA5转阴数和死亡例数方面比较差异均有统计学意义,其中治疗组的DLCO、KL-6和CRP水平均较对照组降低(P<0.01),治疗组FEV1水平较对照组升高(P<0.01),SF水平治疗组较对照组降低(P<0.05)。结论 在MDA5抗体阳性DM伴ILD患者治疗中,给予血浆置换联合PDN、CTX治疗,可以提高疗效,降低病死率。
Objective To explore the effect of plasmapheresis combined with prednisone(PDN)plus cytoxan(CTX)on patients with anti-melanoma differentiation-associated gene 5(MDA 5)antibody-positive dermatomyositis(DM)with interstitial lung disease(ILD). Methods The data of 40 patients with MDA 5 positive DM and ILD diagnosed in the People's Hospital of Pu'er City from June 2014 to June 2023 were retrospectively was analyzed.Twenty patients of the treatment group were treated with plasmapheresis combined with PDN 1mg / kg once daily,which was reduced by 10% per week after 4 weeks.The other 20 patients of the control group were treated with PDN 1mg / kg once daily,which was reduced after 4 weeks by 10% per week,and CTX 1g once per month.diffusing capacity of the lungs for carbon monoxide(DLCO),forced expiratory volume in the first second(FEV1),serum ferritin(SF),C-reactive protein(CRP),Krebs Von den Lungen-6(KL-6)and MDA5 negative conversion rate were measured at 3 and 6 months after treatment,respectively. Results At 3 and 6 months of treatment,complete remission rates of DLCO,FEV1,SF,CRP,KL-6,MDA 5 conversion and other indicators were inconsistent.Among them,at 3 months,the complete response rate of the above indicators in the treatment group was successively:95%,85%,90%,90%,90% and 85%.The control group was 15%,20%,20%,15%,and 0%,0%.Statistical analysis showed that the levels of DLCO,FEV1,SF,CRP,KL-6 and MDA 5 significantly varied at 3 months of treatment.Pairwise comparison of LSD found that the DLCO,KL-6 and CRP levels in the treatment group were significantly lower than the control group(P<0.01),the FEV1 level in the treatment group was significantly higher(P<0.01),and the SF level in the treatment group was significantly lower(P<0.05).After 6 month of treatment,the complete response rate of the above indicators in the treatment group were 95%,85%,90%,90%,90% and 85%,and the complete response rate of the above indicators in the control group was 20%,25%,20%,20%,20% and 5%.Statistical analysis showed the levels of DLCO,FEV1,SF,CRP,KL-6 for the amount of MDA 5 and the number of deaths between two groups were significantly different.Further pairwise comparison of LSD showed that the DLCO,KL-6 and CRP levels in the treatment group were significantly lower compared with the control group(P<0.01),the FEV1 level was significantly increased compared with the control group(P<0.01),and the SF treatment group was significantly decreased compared with the control group(P<0.05). Conclusions In the treatment of patients with MDA 5 antibody positive DM with ILD,the treatment of plasmapheresis combined with PDN and CTX can significantly improve the efficacy and reduce the mortality rate.
论著

80例局部宫颈癌根治性同步放化疗的临床疗效及预后影响因素

Clinical efficacy and prognostic factors of curative synchronous radiotherapy and chemotherapy for 80 cases of local cervical cancer

:1350-1356
 
目的 探讨80例局部宫颈癌根治性同步放化疗的临床疗效及预后影响因素。方法 选取鹤壁市妇幼保健院2018年1月—2021年1月收治的80例宫颈癌患者进行回顾性分析,患者依照其病变程度均采取积极的手术与同步放化疗,其中40例患者采取单纯化疗,将其分为化疗组,40例患者采取同步放化疗,将其分为同步放化疗组,分析其近远期临床疗效与不良反应发生率。对所有患者进行3年随访,将患者分为两个亚组,即预后不良组(n=20)和预后良好组(n=60),对比两组患者一般临床特征,应用Logistic回归模型分析局部宫颈癌根治性同步放化疗的预后影响因素。结果 同步放化疗组ORR、DCR高与化疗组(P<0.05),对照组中位无进展生存期为5.4(2.38~14.52)个月。观察组中位无进展生存期为6.66(2~20.1)个月,观察组高于对照组(χ2=4.536,P=0.041);同步放化疗组盆腔积液、阴道炎症、泌尿生殖道反应、直肠反应、骨髓抑制、胃肠道反应发生率略高于化疗组,但两组对比差异无统计学意义(P>0.05);预后良好组与预后不良组患者年龄、是否绝经、病理类型、肿瘤大小对比差异无统计学意义(P>0.05),预后良好组与预后不良组患者临床分期、组织分化程度、淋巴结转移、是否同步放化疗、治疗前血红蛋白水平对比差异有统计学意义(P<0.05);组织分化程度低、未同步放化疗、治疗前血红蛋白水平低为局部宫颈癌的预后不良影响因素(P<0.05)。结论 对局部宫颈癌患者采取根治性同步放化疗与单一化疗相比可提升其临床疗效与远期生存率,同时安全性较高。组织分化程度低、未同步放化疗、治疗前血红蛋白水平低为宫颈癌预后不良影响因素。
Objective To explore the clinical efficacy and prognostic factors of 80 cases of local cervical cancer treated with radical synchronous radiotherapy and chemotherapy.Methods A retrospective analysis was conducted on 80 cervical cancer patients admitted to Hebi Maternal and Child Health Hospital from January 2018 to January 2021.Patients underwent surgery and synchronous radiotherapy and chemotherapy according to their degree of lesion.Among them,40 patients received simple chemotherapy and were divided into a chemotherapy group,while 40 patients received synchronous radiotherapy and chemotherapy and were divided into a synchronous radiotherapy and chemotherapy group.The short-term and long-term clinical efficacy and incidence of adverse reactions were analyzed.A 3-year follow-up was conducted on all patients,and patients were divided into two subgroups,namely the poor prognosis group(n=20)and the good prognosis group(n=60).The general clinical characteristics of the two groups of patients were compared,and a Logistic regression model was used to analyze the prognostic factors of local cervical cancer radical synchronous radiotherapy and chemotherapy.Results The objective relief rate and disease control rate of the synchronous radiotherapy and chemotherapy group were significantly higher than those of the chemotherapy group(P<0.05),and the median progression free survival of the control group was 5.4(2.38-14.52)months.The median progression free survival of the observation group was 6.66(2-20.1)months,which was higher than that of the control group(χ2=4.536,P=0.041).The incidence of pelvic fluid accumulation,vaginitis,urogenital reactions,rectal reactions,bone marrow suppression,and gastrointestinal reactions in the synchronous radiotherapy and chemotherapy group was slightly higher than that in the chemotherapy group,but there was no statistically significant difference between the two groups(P>0.05).There was no statistically significant difference in age,menopause,pathological type,and tumor size between the patients with good prognosis and those with poor prognosis(P>0.05).However,there was a statistically significant difference in clinical stage,tissue differentiation,lymph node metastasis,synchronous radiotherapy and chemotherapy,and pre-treatment hemoglobin levels between the patients with good prognosis and those with poor prognosis(P<0.05).Low degree of tissue differentiation,lack of synchronous radiotherapy and chemotherapy,and low hemoglobin levels before treatment were adverse prognostic factors for local cervical cancer(P<0.05).Conclusion sCompared with single radiotherapy,radical synchronous radiotherapy and chemotherapy can improve the clinical efficacy and long-term survival rate of patients with local cervical cancer,with higher safety.The severe tissue differentiation,unsynchronized chemoradiotherapy and hemoglobin before treatment were the adverse prognostic factors of cervical cancer.
论著

ICP监测联合浮动骨瓣减压术治疗颅脑损伤的临床疗效

Clinical efficacy of ICP monitoring combined with floating bone flap decompression for craniocerebral injury

:79-82
 
目的 研究颅内压(ICP)监测联合浮动骨瓣减压术在治疗颅脑损伤中对颅内压及脑血流指标的影响。方法 选取我院2019年3月—2021年3月收治的拟行骨瓣减压术的颅脑损伤患者106例作为研究对象,按照手术方法不同分为对照组(n=53)、观察组(n=53)。对照组采用传统去骨瓣减压术(DC)治疗,观察组采用ICP监测联合浮动骨瓣减压术治疗。对比2组ICP、脑血流指标[平均流速(Vm)、收缩期血流速度(Vs)、血管搏动指数(PI)]及并发症发生情况。结果 术后1、3、7 d观察组ICP、PI低于对照组,Vm、Vs高于对照组(P<0.05);术后观察组并发症总发生率9.43%低于对照组37.74%(P<0.05)。结论 采用ICP监测联合浮动骨瓣减压术治疗颅脑损伤能降低患者ICP,改善脑血流状态,降低术后并发症,避免二次手术,减轻患者经济负担。
Objective To study the effect of intracranial pressure (ICP) monitoring combined with floating bone flap decompression on intracranial pressure and cerebral blood flow index in the treatment of craniocerebral injury. Methods A total of 106 patients admitted to our hospital from March 2019 to March 2021 were selected as study subjects and divided into control group (n=53) and observation group (n=53).The control group was treated with traditional decompressed craniectomy (DC), and the observation group was treated with ICP monitoring combined with floating bone flap decompression.The ICP, cerebral blood flow index [mean flow velocity (Vm), systolic flow velocity (Vs), vascular pulsatility index (PI)] and complications were compared between the two groups. Results ICP and PI were lower in observation groups on 1,3 and 7 d, Vm and Vs were higher (P <0.05); the incidences of complications in observation group (9.43%), such as electrolyte disorder, pulmonary infection, abnormal renal function and incisional hernia, were lower in the control group (37.74%, P<0.05). Conclusions ICP monitoring combined with floating bone flap decompression could reduce ICP, improve cerebral blood flow, reduce postoperative complications, avoid secondary surgery and reduce economic burden.
论著

化疗联合调强放疗治疗老年(≥65岁)局部晚期鼻咽癌的临床疗效

Clinical efficacy of chemotherapy combined with intensity-modulated radiotherapy in the treatment of elderly(≥65 years old)locally advanced nasopharyngeal carcinoma

:40-44
 
目的 探析化疗联合调强放疗(IMRT)治疗老年(≥65岁)局部晚期鼻咽癌的临床效果。方法 选取2018年1月—2019年1月我院诊治的90例老年局部晚期鼻咽癌患者为研究对象,使用随机数表法将此90例患者分为观察组及对照组,各45例。观察组行IMRT,对照组行化疗联合IMRT,对比2组的效果。结果 2组的治疗总有效率均为100%,组间差异不显著(P<0.05)。观察组的生活质量改善率(93.33%)高于对照组(77.78%)(P<0.05)。对照组出现3~4级白细胞减少、呕吐、黏膜炎人数明显高于观察组(P<0.05),两者其他毒副反应比较无显著差异(P>0.05)。观察组的1年总体生存率(91.11%)及3年总体生存率(75.56%)均高于对照组(86.67%、68.89%)(P<0.05)。结论 对于老年局部晚期鼻咽癌,化疗联合IMRT相比单纯IMRT降低了远期生存率,增加了毒副反应并影响疗后生活质量的改善,不宜常规应用,单纯IMRT可能是更合适的治疗选择。
Objective To explore the clinical effect of chemotherapy combined with intensity modulated radiation therapy(IMRT)in the treatment of elderly(≥65 years old)locally advanced nasopharyngeal carcinoma.Methods The study was carried out from January 2018 to January 2019.During this period,90 elderly patients with locally advanced nasopharyngeal carcinoma who were diagnosed and treated in our hospital were selected as the research objects.The random number table method was used to divide the 90 patients into observation groups,and the control group,each with 45 cases.The observation group was treated with IMRT,and the control group was treated with chemotherapy combined with IMRT.The effects of the two groups were compared.Results The total effective rate of the two groups was 100%,and there was no significant difference between the two groups(P<0.05).The improvement rate of quality of life in the observation group(93.33%)was higher than that in the control group(77.78%,P<0.05).The number of grade 3-4 leukopenia,vomiting and mucositis in the control group was significantly higher than that in the observation group(P<0.05),and there was no significant difference in other side effects between the two groups(P>0.05).The 1-year overall survival rate(91.11%)and 3-year overall survival rate(75.56%)of the observation group were higher than those of the control group(86.67%,68.89%,P<0.05).Conclusions For locally advanced nasopharyngeal carcinoma in the elderly,chemotherapy combined with IMRT reduces the long-term survival rate,increases the toxic and side effects and affects the improvement of the quality of life after treatment.It is not suitable for routine application,and IMRT alone may be a more appropriate treatment choice.
出版者信息








《广州医药》公众号